Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
22 /100
LOW RISK
Score updated Aug 28, 2026

CABA — Cabaletta Bio, Inc. Dilution Risk Tracker

Track CABA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CABA — Get alerts when the score changes →

As of August 28, 2026, Cabaletta Bio, Inc. (CABA) has a DilutionWatch DilutionScore of 22/100, rated LOW dilution risk. Cabaletta Bio, Inc. has a market capitalization of $616.35M, 169.55M shares outstanding, 112 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $150.00M, 3.09M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
50
💰 Cash Runway
10
📊 Float Risk
12
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 9%
💰 Capital Raise model 18%
• Active ATM program with $150M remaining capacity
🔔 Track CABA — Get forecast alerts →

Market Data

Market Cap$616.35M
Shares Outstanding169.55M
Float142.90M
Cash$225.10M
DebtN/A
Short InterestN/A

Institutional Holdings

QoQ: ↑ 18.8% shares (2026Q1 vs prior)
112 institutional holders · 97.34M shares
#1 T. Rowe Price Investment Management, Inc. 11.08M shares
#2 Bain Capital Life Sciences Investors, LLC 9.68M shares
#3 JENNISON ASSOCIATES LLC 8.97M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest40.78M
Days to Cover18.4
% of Float28.5%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30
xbrl XBRL CONVERTIBLE 2018-12-31
8-K 8K EVENT 2026-05-04
424B5 ATM 2026-05-04
4 INSIDER TRANSACTION 2026-03-02
Full SEC filing analysis available with free account

Recent News

No recent news

Factual CABA Dilution Snapshot

Cabaletta Bio, Inc. (CABA) has a DilutionScore of 22/100, rated Low dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track CABA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CABA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for CABA
CABA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.